This dual benefit of appetite control and blood sugar regulation is one reason why GLP-1 agonists are considered a promising treatment for both obesity and type 2 diabetes
Available at: (Accessed: 16 March 2026) Initial clinical trials with tirzepatide found that the drug successfully controlled type 2 diabetes while simultaneously resulting in significant weight loss in many users
The absence of water eliminates hydrolysis risk
For patients comparing these medications, understanding their side effect profiles , the dosage comparison chart , and the overall comparison between semaglutide and tirzepatide provides much more actionable information than visual inspection
Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors a mechanism that sets it apart from approved agents such as semaglutide and tirzepatide
Aetna coverage for Ozempic is more likely if prescribed for either of these FDA-approved indications